OA04814A - Procédé de préparation d'un composé antihistaminique. - Google Patents

Procédé de préparation d'un composé antihistaminique.

Info

Publication number
OA04814A
OA04814A OA55247A OA55247A OA04814A OA 04814 A OA04814 A OA 04814A OA 55247 A OA55247 A OA 55247A OA 55247 A OA55247 A OA 55247A OA 04814 A OA04814 A OA 04814A
Authority
OA
OAPI
Prior art keywords
preparing
antihistamine compound
antihistamine
compound
Prior art date
Application number
OA55247A
Other languages
English (en)
Inventor
Graham John Durant
Charon Robin Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of OA04814A publication Critical patent/OA04814A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA55247A 1973-07-13 1974-07-12 Procédé de préparation d'un composé antihistaminique. OA04814A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3342873A GB1431589A (en) 1973-07-13 1973-07-13 Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups

Publications (1)

Publication Number Publication Date
OA04814A true OA04814A (fr) 1980-10-31

Family

ID=10352834

Family Applications (1)

Application Number Title Priority Date Filing Date
OA55247A OA04814A (fr) 1973-07-13 1974-07-12 Procédé de préparation d'un composé antihistaminique.

Country Status (31)

Country Link
US (1) US4499101A (fr)
JP (1) JPS5830314B2 (fr)
AR (3) AR204928A1 (fr)
AT (1) AT346855B (fr)
BE (1) BE816850A (fr)
BG (1) BG25792A3 (fr)
CA (1) CA1049524A (fr)
CH (1) CH601252A5 (fr)
CS (1) CS199255B2 (fr)
DD (1) DD112449A5 (fr)
DE (1) DE2433625A1 (fr)
DK (1) DK334674A (fr)
EG (1) EG11259A (fr)
ES (3) ES428246A1 (fr)
FI (1) FI213274A (fr)
FR (1) FR2274298A1 (fr)
GB (1) GB1431589A (fr)
HU (1) HU169394B (fr)
IE (1) IE39607B1 (fr)
IL (1) IL45006A (fr)
IN (1) IN140943B (fr)
LU (1) LU70507A1 (fr)
MW (1) MW2674A1 (fr)
NL (1) NL7408942A (fr)
NO (1) NO143063C (fr)
OA (1) OA04814A (fr)
PH (1) PH11618A (fr)
PL (3) PL98705B1 (fr)
SE (1) SE416202B (fr)
SU (3) SU559647A3 (fr)
ZM (1) ZM10374A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215125A (en) 1973-07-13 1980-07-29 Smith Kline & French Laboratories Limited Pyridyl ureas, thioureas and guanidines
US4062967A (en) * 1974-02-07 1977-12-13 Smith Kline & French Laboratories Limited Bis-guanidino-alkane compounds
US4151289A (en) 1975-01-22 1979-04-24 Smith Kline & French Laboratories Limited Nitromethylene amidino derivatives containing imidazole groups
GB1542840A (en) * 1975-02-03 1979-03-28 Smith Kline French Lab Heterocyclic dithiocarbamates and isothioureas
US4120972A (en) 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Imidazolylmethylthio-ethyl isothiourea compounds
IL49528A (en) 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
GR62452B (en) 1977-04-20 1979-04-12 Ici Ltd Preparation process of guanidine derivatives
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
JPS5610175A (en) * 1979-07-06 1981-02-02 Fujisawa Pharmaceut Co Ltd Preparation of imidazole derivative
JPS5775975A (en) * 1980-08-27 1982-05-12 Glaxo Group Ltd Heterocyclic derivative, manufacture and medicinal composition containing same
EP0089765A3 (fr) * 1982-03-17 1984-05-23 Smith Kline & French Laboratories Limited Dérivés de pyridine
EP0199845B1 (fr) 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Dérivés d'imidazolylalkylguanidine, leur procédé de préparation et compositions les contenant
DE3512084A1 (de) * 1985-04-02 1986-10-09 Ludwig Heumann & Co GmbH, 8500 Nürnberg Guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH06505265A (ja) * 1991-02-27 1994-06-16 シード・キャピタル・インベストメント・(エス・シー・アイ)・ベスローテン・フェンノートシャップ ヒスタミンh↓3受容体に対する作動的または拮抗的活性を有するイミダゾール誘導体
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
US7041702B1 (en) 1997-10-21 2006-05-09 Scion Pharmaceuticals, Inc. Pharmaceutically active compounds and methods of use
WO1999020599A1 (fr) * 1997-10-21 1999-04-29 Cambridge Neuroscience, Inc. Composes pharmaceutiquement actifs et procedes d'utilisation
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632032A (fr) * 1962-05-09
CH484918A (de) * 1965-10-28 1970-01-31 Ciba Geigy Verfahren zur Herstellung heterocyclischer, Aethylendoppelbindungen enthaltender Verbindungen
US3770755A (en) * 1967-09-26 1973-11-06 Ici Ltd 4-(4-bromophenyl)-2-(2-hydroxysopropyl) thiazole
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
US3749728A (en) * 1972-02-15 1973-07-31 Smith Kline French Lab N-cycloalkyl and n-cycloalkane-alkylthioamides
US3821229A (en) * 1972-12-07 1974-06-28 American Cyanamid Co Diquaternary salts of di-4-pyridyl ketone
US4013659A (en) * 1973-07-13 1977-03-22 Smith Kline & French Laboratories Limited Certain n,n'-disubstituted guanidine compounds and their use
US4156727A (en) * 1975-07-31 1979-05-29 Smith Kline & French Laboratories Limited Alkoxy pyridine compounds

Also Published As

Publication number Publication date
LU70507A1 (fr) 1974-11-28
NO143063C (no) 1980-12-10
AR202618A1 (es) 1975-06-24
IE39607B1 (en) 1978-11-22
SE7409188L (sv) 1975-01-14
AR202617A1 (es) 1975-06-24
SU567405A3 (ru) 1977-07-30
NO143063B (no) 1980-09-01
JPS5032174A (fr) 1975-03-28
FR2274298A1 (fr) 1976-01-09
CS199255B2 (en) 1980-07-31
IL45006A0 (en) 1974-09-10
ES437770A1 (es) 1977-01-16
NO742563L (fr) 1975-02-10
NL7408942A (nl) 1975-01-15
AR204928A1 (es) 1976-03-19
ES428246A1 (es) 1976-07-16
AT346855B (de) 1978-11-27
EG11259A (en) 1977-01-31
DE2433625A1 (de) 1975-01-30
FI213274A (fr) 1975-01-14
AU6984574A (en) 1975-12-11
ES437769A1 (es) 1977-02-01
PH11618A (en) 1978-04-12
IL45006A (en) 1978-07-31
BG25792A3 (en) 1978-12-12
JPS5830314B2 (ja) 1983-06-28
ZM10374A1 (en) 1975-04-21
DK334674A (fr) 1975-03-03
IN140943B (fr) 1977-01-01
BE816850A (fr) 1974-12-27
HU169394B (fr) 1976-11-28
PL98609B1 (pl) 1978-05-31
IE39607L (en) 1975-01-13
CH601252A5 (fr) 1978-06-30
SE416202B (sv) 1980-12-08
SU571193A3 (ru) 1977-08-30
FR2274298B1 (fr) 1978-07-21
DD112449A5 (fr) 1975-04-12
MW2674A1 (en) 1975-05-13
PL96460B1 (pl) 1977-12-31
PL98705B1 (pl) 1978-05-31
ATA552674A (de) 1978-04-15
GB1431589A (en) 1976-04-07
CA1049524A (fr) 1979-02-27
US4499101A (en) 1985-02-12
SU559647A3 (ru) 1977-05-25

Similar Documents

Publication Publication Date Title
OA04814A (fr) Procédé de préparation d'un composé antihistaminique.
OA04852A (fr) Procédé de préparation de 1,3-dihydrospiro[isobenzofurannes] substitués.
CH526989A (fr) Procédé de préparation d'un catalysateur de polymérisation
YU261974A (en) Process for obtaining hexahydro-dibenzo-(b,d)pyran-9-one compounds
OA06089A (fr) Procédé de préparation d'un sel de vincamine.
OA04809A (fr) Procédé de préparation d'a-aminoacyl-3-halocépha-losporines.
OA05096A (fr) Procédé de préparation de composés hétérocycliques.
CA1010040A (en) PROCESS FOR PREPARING A 2-(.omega.-AMINOALKYL)-1,3-HETEROCYCLIC COMPOUNDS
OA05241A (fr) Procédé de préparation d'E-(-glutamyl)-lysine.
CH528502A (fr) Procédé de préparation de -lactones a,B-insaturées
CH498824A (fr) Procédé pour la préparation d'un composé carbonylé
OA04265A (fr) Procédé d'obtention de composés d'uranium.
CH534154A (fr) Procédé de préparation d'un 3-aryloxy-8-carbamoylnortropane
CH529747A (fr) Procédé de préparation d'un composé chromone
CH529765A (fr) Procédé de préparation d'un composé iminobenzyl-pyrazole
CH524642A (fr) Procédé de préparation d'un composé enzymatique
BE785488A (fr) Procede de preparation d'un compose heterocyclique
CH400137A (fr) Procédé de préparation d'un composé polyfluoroalicyclique
FR95841E (fr) Procédé de préparation d'un composé a noyaux superposés.
OA00606A (fr) Procédé de préparation d'un nouveau nicotinate.
CH428722A (fr) Procédé de préparation d'un 16a-éthynyl-19-nor-1,3,5(10)-androstatriène
BE765324A (fr) Procede de preparation d'un polychlorophenol, de haute purete
CH534685A (fr) Procédé de préparation d'une pipérazine
FR1488760A (fr) Procédé de préparation d'un composé de siloxyméthylsiloxyle distillable
OA04818A (fr) Procédé de préparation d'éthers de dihydro-3, 4 benzoxépines-1 one-5-oxime.